Skip to content

Hawkins HWKN Food & Health Sciences — D&A

Other segment segments

Food and Health Sciences
$12.9M
Water Treatment
$8.13M+53.9%
Industrial Solutions
$2.26M

Similar metrics at other companies

POS
POSTFoodservice — D&A
$35.5M+10.6%
Conagra Brands logo
CAGFoodservice — D&A
$11.6M0.0%
POS
POSTFoodservice Segment — D&A
$35.5M+10.6%
Balchem logo
BCPCHuman Nutrition and Health — D&A
$8.65M+18.4%
The Marzetti Company Common Stock logo
MZTIRetail & Foodservice — D&A
$15.95M+9.8%
Balchem logo
BCPCAnimal Nutrition and Health — D&A
$1.86M+5.6%

Other financials

Income statement

See full
Revenue$265.9M+8.4%
Gross profit$54.2M+3.8%
Operating income$23.5M-4.5%
Net income$15.5M-5.3%
EPS (diluted)$0.74-5.1%

Balance sheet

See full
Cash & equivalents$3.9M-23.3%
Total debt$261.5M+51.4%
Total equity$534.0M+16.0%
Total assets$986.3M+28.1%

Cash flow

See full
Operating cash flow$37.7M+22.3%
CapEx$19.6M+76.6%
Free cash flow$18.2M-8.1%

Valuation

See full
Market cap$3.42B+44.8%

Profitability

See full
Gross margin22.6%-0.5pp
Operating margin11.2%-1.0pp
Net margin7.5%-1.1pp
FCF margin7.9%+0.8pp

Returns & leverage

See full
Return on equity16.4%-3.1pp
Debt / equity0.5×+0.1×
Current ratio2.2×-0.2×

Where this comes from

Reported directly by Hawkins in its filing.

Tagged under the XBRL concept us-gaap:DepreciationDepletionAndAmortization.

The official record: Hawkins’s 10-Q, filed January 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Hawkins's food & health sciences — d&a.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Hawkins's food & health sciences — D&A?
Hawkins (HWKN) reported food & health sciences — D&A of $3.29M in Q4 2025.
How has Hawkins's food & health sciences — D&A changed year-over-year?
Hawkins's food & health sciences — D&A increased by 4.4% year-over-year, from $3.15M to $3.29M.
What does food & health sciences — D&A mean?
This metric represents the non-cash expense allocated to the Food & Health Sciences segment for the wear and tear of tangible assets and the systematic write-off of intangible assets over their useful lives. It reflects the capital intensity of the segment's manufacturing and processing infrastructure. Monitoring this figure helps investors assess the segment's ongoing investment in production capacity and the impact of asset aging on operating margins.